INS and obesity due to melanocortin 4 receptor deficiency: The fact that exenatide treatment had no effect on insulin levels, but improved glucose tolerance and, as previously shown had an effect on weight and BMI-SDS (13), makes it an interesting candidate for the treatment of obesity during adolescence without the risk of altering insulin during growth.